Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms

Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms

Abstract Deaths connected to bacterial infections are expected to outnumber those caused by cancer by 2050. Multiple advantages, including enhanced efficacy of the treatment, characterize the use of nanocarriers to deliver antibiotics. This work explores the use of mucosomes – intrinsically glycosyl...

Full description

Saved in:
Bibliographic Details
Main Authors: Giuseppe Guagliano, Emanuela Peluso, Cosmin Stefan Butnarasu, Elisa Restivo, Lorenzo Sardelli, Enrica Frasca, Paola Petrini, Nicola Tirelli, Stefania Sganga, Livia Visai, Sonja Visentin
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Mucin
Mucosa
Infections
Drug delivery
Ciprofloxacin
Nanoparticles
Online Access:https://doi.org/10.1038/s41598-025-10496-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-10496-y

Similar Items